Related Experiment Video
Updated: Aug 5, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization
Mohamed S Al Riyami1, Badria Al Ghaithi1, Sulaiman Al Saidi1
1Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, Muscat PC 111, Oman.
Insights
Childhood-onset lupus nephritis (cLN) requires specialized care beyond adult models. The focus is now on durable kidney response with minimal toxicity to preserve function and development.
Area of Science:
- Pediatric Nephrology
- Immunology
- Rheumatology
Background:
- Childhood-onset lupus nephritis (cLN) is a severe pediatric kidney disease with long-term implications.
- 10-20% of systemic lupus erythematosus (SLE) cases begin in childhood, with 40-60% developing lupus nephritis.
- Some populations show higher renal involvement, up to 73% in Saudi children with SLE.
Purpose of the Study:
- To reframe the management of cLN from merely inducing remission to achieving durable kidney response with reduced toxicity.
- To emphasize the need for developmentally informed, sustainable treatment strategies in pediatric lupus nephritis.
- To highlight the intersection of immune injury, treatment toxicity, growth, puberty, fertility, and care transition in cLN.
Main Methods:
- Shift from prolonged high-dose glucocorticoids and cyclophosphamide to biopsy-driven, treat-to-target approaches.
- Incorporation of mycophenolic acid analogues, hydroxychloroquine, and nephroprotection.
- Consideration of belimumab or calcineurin inhibitors in select triple therapy regimens.
Main Results:
- Contemporary guidance favors rapid steroid tapering and targeted therapies.
- The goal is to achieve sustained remission while minimizing cumulative toxicity.
- Focus on preserving kidney function and promoting normal childhood development.
Conclusions:
- cLN management must prioritize long-term kidney health and child development over short-term remission.
- Pediatric practice needs to integrate adult trial data with child-specific considerations, including adherence, fertility, and transition planning.
- The aim is intelligent, sustainable treatment balancing efficacy and minimal toxicity for improved long-term outcomes.
Abstract:
Childhood-onset lupus nephritis (cLN) should no longer be framed as a smaller version of adult lupus nephritis. It is a high-stakes pediatric kidney disease in which immune injury, treatment toxicity, growth, puberty, fertility, adherence, and transition to adult care intersect over decades. Approximately 10-20% of systemic lupus erythematosus begins in childhood, and 40-60% of affected children develop lupus nephritis. Regional cohorts report even higher renal involvement in some populations, including 65-73% among Saudi children with SLE. Contemporary guidance has moved from prolonged high-dose glucocorticoids and cyclophosphamide-dominant treatment toward biopsy-driven, treat-to-target care built around mycophenolic acid analogues, hydroxychloroquine, nephroprotection, rapid steroid tapering, and selected belimumab- or calcineurin-inhibitor-based triple therapy. This Viewpoint argues that the central question in cLN is no longer simply how to induce remission, but how to produce a durable kidney response early enough, with sufficiently low cumulative toxicity, to preserve kidney function and childhood development. Pediatric practice must therefore combine adult trial evidence with child-specific caution, explicit adherence strategies, fertility and growth protection, and structured transition planning. The aim should be efficacy without toxicity: not undertreatment, but intelligent, sustainable, developmentally informed treatment.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure